VIA
ORTX

Vident Investment Advisory’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Vident Investment Advisory’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,381
Closed -$192K – 1256
2021
Q2 		$192K Buy
+4,381
New +$244K 0.01% 1066

Other funds holding ORTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vident Investment Advisory's ORTX Position: Q3 2021 in Review

Vident Investment Advisory sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 4,381 shares — an estimated $192K sold.

Vident Investment Advisory first reported a position in ORTX in Q2 2021 and held it in 1 quarter. The position peaked at $192K in Q2 2021. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

  • Vident Investment Advisory reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Vident Investment Advisory sold 4,381 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $192K.
  • Vident Investment Advisory first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2021 and held it in 1 quarter.
  • Vident Investment Advisory's Orchard Therapeutics plc American Depositary Shares position peaked at $192K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on Vident Investment Advisory's 13F filing for Q3 2021, filed 12 Nov 2021.